Treatment outcomes of oral sitafloxacin in acute complicated urinary tract infection and pyelonephritis

BACKGROUND: Data on the success rate of sitafloxacin treatment in acute complicated urinary tract infection and pyelonephritis are limited. OBJECTIVES: To determine the success rate of a new oral fluoroquinolone, sitafloxacin, in acute complicated urinary tract infection and pyelonephritis. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Manosuthi, Weerawat, Wiboonchutikul, Surasak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821846/
https://www.ncbi.nlm.nih.gov/pubmed/27069830
http://dx.doi.org/10.1186/s40064-016-2044-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821846/
https://www.ncbi.nlm.nih.gov/pubmed/27069830
http://dx.doi.org/10.1186/s40064-016-2044-5

Ejemplares similares